Mucocutaneous Leishmaniasis

A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.

Also Known As:

Leishmaniasis, Mucocutaneous; Leishmaniases, Mucocutaneous; Mucocutaneous Leishmaniases

Infections: 539155
- Parasitic Diseases: 4973
  - Protozoan Infections: 287
    - Euglenozoa Infections
      - Leishmaniasis: 5099
        Cutaneous Leishmaniasis: 2767
        Mucocutaneous Leishmaniasis: 138
  - Parasitic Skin Diseases: 13
    - Leishmaniasis: 5099
      - Cutaneous Leishmaniasis: 2767
        Mucocutaneous Leishmaniasis: 138
- Vector Borne Diseases: 391
  - Leishmaniasis: 5099
    - Cutaneous Leishmaniasis: 2767
      - Mucocutaneous Leishmaniasis: 138
Skin and Connective Tissue Diseases
- Skin Diseases: 13402
  - Infectious Skin Diseases: 46
    - Parasitic Skin Diseases: 13
      - Leishmaniasis: 5099
        Cutaneous Leishmaniasis: 2767
        Mucocutaneous Leishmaniasis: 138

Sobhana Kumari Selected Research

Sobhana Kumari Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure